Search Results - "Pupa, SM"

Refine Results
  1. 1

    New insights into the role of extracellular matrix during tumor onset and progression by Pupa, Serenella M., Ménard, Sylvie, Forti, Stefania, Tagliabue, Elda

    Published in Journal of cellular physiology (01-09-2002)
    “…Recently, a view of the tumor as a functional tissue interconnected with the microenvironment has recently been described. For many years, the stroma has been…”
    Get full text
    Journal Article
  2. 2

    Biologic and therapeutic role of HER2 in cancer by Ménard, Sylvie, Pupa, Serenella Marja, Campiglio, Manuela, Tagliabue, Elda

    Published in Oncogene (29-09-2003)
    “…Overexpression of the human epidermal growth factor-2 (HER2) oncogene in human breast carcinomas has been associated with a more aggressive course of disease…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Role of HER2 gene overexpression in breast carcinoma by Ménard, Sylvie, Tagliabue, Elda, Campiglio, Manuela, Pupa, Serenella M.

    Published in Journal of cellular physiology (01-02-2000)
    “…The HER2 proto‐oncogene encodes a transmembrane glycoprotein of 185 kDa (p185HER2) with intrinsic tyrosine kinase activity. Amplification of the HER2 gene and…”
    Get full text
    Journal Article
  5. 5

    Abstract P5-18-10: Chemotherapy can enhance trastuzumab-mediated ADCC by Tagliabue, E, Sfondrini, L, Regondi, V, Casalini, P, Pupa, SM, Sommariva, M, Balsari, A, Triulzi, T

    Published in Cancer research (Chicago, Ill.) (15-12-2012)
    “…Trastuzumab, a recombinant humanized monoclonal antibody directed to the HER2 protein, has shown survival benefits in women with HER2-positive breast cancer,…”
    Get full text
    Journal Article
  6. 6

    Role of exon-16-deleted HER2 in breast carcinomas by Castiglioni, F, Tagliabue, E, Campiglio, M, Pupa, S M, Balsari, A, Ménard, S

    Published in Endocrine-related cancer (01-03-2006)
    “…A splice variant of the human gene HER2, lacking exon-16 (ΔHER2) which encodes a small extracellular region, has been described. This altered receptor forms…”
    Get full text
    Journal Article
  7. 7

    Electroporated DNA vaccine clears away multifocal mammary carcinomas in Her-2/neu transgenic mice by QUAGLINO, Elena, IEZZI, Manuela, LOLLINI, Pier Luigi, MUSIANI, Piero, FORNI, Guido, CAVALLO, Federica, MASTINI, Cristina, AMICI, Augusto, PERICLE, Federica, DI CARLO, Emma, PUPA, Serenella M, DE GIOVANNI, Carla, SPADARO, Michela, CURCIO, Claudia

    Published in Cancer research (Chicago, Ill.) (15-04-2004)
    “…The transforming rat Her-2/neu oncogene embedded into the genome of virgin transgenic BALB/c mice (BALB-neuT) provokes the development of an invasive carcinoma…”
    Get full text
    Journal Article
  8. 8

    P5-14-06: Interaction between Stoma and Tumor Characteristics as a New Prognostic and Predictive Marker in Breast Carcinomas by Tagliabue, E, Sandri, M, Casalini, P, Aiello, P, Pupa, SM, Orlandi, R, Balsari, A, Triulzi, T

    Published in Cancer research (Chicago, Ill.) (15-12-2011)
    “…Background. We recently demonstrated that primary breast tumors can be classified based upon extracellular matrix composition (ECM) (Bergamaschi et al.)…”
    Get full text
    Journal Article
  9. 9

    Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice by Nanni, P, Nicoletti, G, De Giovanni, C, Landuzzi, L, Di Carlo, E, Cavallo, F, Pupa, S M, Rossi, I, Colombo, M P, Ricci, C, Astolfi, A, Musiani, P, Forni, G, Lollini, P L

    Published in The Journal of experimental medicine (05-11-2001)
    “…Transgenic Balb/c mice expressing the transforming rat HER-2/neu oncogene develop early and multifocal mammary carcinomas. Within the first 5 months of life…”
    Get full text
    Journal Article
  10. 10

    The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1 by Berno, V, Porrini, D, Castiglioni, F, Campiglio, M, Casalini, P, Pupa, S M, Balsari, A, Ménard, S, Tagliabue, E

    Published in Endocrine-related cancer (01-06-2005)
    “…The association between expression of the 67 kDa laminin receptor (67LR) and tumor aggressiveness has been convincingly demonstrated although the exact…”
    Get full text
    Journal Article
  11. 11

    High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer by Disis, M L, Pupa, S M, Gralow, J R, Dittadi, R, Menard, S, Cheever, M A

    Published in Journal of clinical oncology (01-11-1997)
    “…To evaluate HER-2/neu-specific antibody immunity in patients with breast cancer, to determine the rate of occurrence of serum antibodies to HER-2/neu in…”
    Get more information
    Journal Article
  12. 12

    HER-2: A biomarker at the crossroads of breast cancer immunotherapy and molecular medicine by Pupa, Serenella M., Tagliabue, Elda, Ménard, Sylvie, Anichini, Andrea

    Published in Journal of cellular physiology (01-10-2005)
    “…The oncoprotein encoded by the HER‐2 oncogene is a member of the HER family of receptor tyrosine kinases and is actually the first successfully exploited…”
    Get full text
    Journal Article
  13. 13

    Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination by PUPA, Serenella M, IEZZI, Manuela, DI CARLO, Emma, INVERNIZZI, Annamaria, CAVALLO, Federica, MEAZZA, Raffaella, COMES, Alberto, FERRINI, Silvano, MUSIANI, Piero, MENARD, Sylvie

    Published in Cancer research (Chicago, Ill.) (01-02-2005)
    “…Plasmid DNA vectors encoding the full-length (VR1012/HER-2-FL) or only the extracellular and transmembrane domains (VR1012/HER-2-ECD-TM) of human (h) HER-2/neu…”
    Get full text
    Journal Article
  14. 14

    Immunological and pathobiological roles of fibulin-1 in breast cancer by PUPA, Serenella M, ARGRAVES, Scott W, MORTARINI, Roberta, ANICHINI, Andrea, MENARD, Sylvie, FORTI, Stefania, CASALINI, Patrizia, BERNO, Valeria, AGRESTI, Roberto, AIELLO, Piera, INVERNIZZI, Annamaria, BALDASSARI, Paola, OTWAL, Waleed

    Published in Oncogene (18-03-2004)
    “…Fibulin-1 (Fbln-1) is an immunogenic breast cancer-related glycoprotein identified by serological analysis of cDNA expression library (SEREX) strategy. Here,…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination by PUPA, S. M, INVERNIZZI, A. M, FORTI, S, DI CARLO, E, MUSIANI, P, NANNI, P, LOLLINI, P. L, MEAZZA, R, FERRINI, S, MENARD, S

    Published in Gene therapy (2001)
    “…The HER-2/neu proto-oncogene is overexpressed in 20-30% of human breast cancers and is associated with high recurrence risk. The oncogenic potential of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage by Pupa, S M, Ménard, S, Morelli, D, Pozzi, B, De Palo, G, Colnaghi, M I

    Published in Oncogene (01-11-1993)
    “…A molecule that is immunologically related to the c-erbB-2 oncogene product (p185HER2/neu) was detected in the conditioned culture medium from…”
    Get more information
    Journal Article
  20. 20